Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel

A.D. Adema; AC Laan; F. Myhren; I. Fichtner; H.M.W. Verheul; ML Sandvold; G.J. Peters

doi:https://doi.org/10.3892/ijo_00000499

Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel

A.D. Adema, AC Laan, F. Myhren, I. Fichtner, H.M.W. Verheul, ML Sandvold, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

20 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	285-294
Journal	International journal of oncology
Volume	36
Issue number	1
DOIs	https://doi.org/10.3892/ijo_00000499
Publication status	Published - 2010

Access to Document

https://doi.org/10.3892/ijo_00000499

Cite this

@article{e9d83135ca1c4c87ab19421654244927,

title = "Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel",

author = "A.D. Adema and AC Laan and F. Myhren and I. Fichtner and H.M.W. Verheul and ML Sandvold and G.J. Peters",

year = "2010",

doi = "https://doi.org/10.3892/ijo_00000499",

language = "Undefined/Unknown",

volume = "36",

pages = "285--294",

journal = "International journal of oncology",

issn = "1019-6439",

publisher = "Spandidos Publications",

number = "1",

}

TY - JOUR

T1 - Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel

AU - Adema, A.D.

AU - Laan, AC

AU - Myhren, F.

AU - Fichtner, I.

AU - Verheul, H.M.W.

AU - Sandvold, ML

AU - Peters, G.J.

PY - 2010

Y1 - 2010

U2 - https://doi.org/10.3892/ijo_00000499

DO - https://doi.org/10.3892/ijo_00000499

M3 - Article

SN - 1019-6439

VL - 36

SP - 285

EP - 294

JO - International journal of oncology

JF - International journal of oncology

IS - 1

ER -